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Background: Genome-wide association studies have identified variants associated with BMI in populations of
European descent. We sought to establish whether genetic variants that are robustly associated with BMI could
modulate anthropometric traits and the obesity risk in an Algerian population sample, the ISOR study.
The ISOR study of 787 adult subjects (aged between 30 and 64) provided a representative sample of the population
living in the city of Oran (north-west of Algeria). We investigated the combined effect of 29 BMI established genetic
variants using a genetic predisposition score (GPS) on anthropometric traits and obesity risk in 740 subjects.
Results: We found that each additional risk allele in the GPS was associated with an increment in the mean [95% CI]
for BMI of 0.15 [0.06 - 0.24] kg/m2 (p = 0.001). Although the GPS was also associated with higher waist (p = 0.02)
and hip (p = 0.02) circumferences, these associations were in fact driven by BMI. The GPS was also associated with
an 11% higher risk of obesity (OR [95%CI] = 1.11 [1.05 - 1.18], p = 0.0004).
Conclusions: Our data showed that a GPS comprising 29 BMI established loci developed from Europeans seems
to be a valid score in a North African population. Our findings contribute to a better understanding of the genetic
susceptibility to obesity in Algeria.
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Obesity (as characterized by excess body fat) is an estab-
lished risk factor for cardiovascular and metabolic dis-
eases. Indeed, each unit increase in the body mass index
(BMI) increases the risk of hypertension by a factor of 5
and the risks of coronary artery disease and stroke by a
factor of 3.6 [1]. It is noteworthy that 80% of people with
type 2 diabetes are obese [2]. Moreover, non-alcoholic
steatohepatitis, impotency, infertility, and several types of
cancer have all been linked to obesity [1]. Overall, obesity
increases the risk of premature death. Obesity has reached
epidemic proportions in modern society [3]. In 2008, more
than 500 million adults worldwide were considered to be* Correspondence: louisa.goumidi@pasteur-lille.fr
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unless otherwise stated.clinically obese [4]. However, the prevalence of obesity
and overweight differs from one region of the world to
another, with 33.5% in the USA [5], 23.1% in Canada [6],
between 5.1% and 32.4% in Europe (with a west/east/south
gradient) [7], 14.9% in Morocco [8], 29.6% in Tunisia [9]
and 21.2% in Algeria [10]. Obesity is increasingly prevalent
in many African countries and other developing coun-
tries undergoing nutritional transitions as a result of
urbanization, demographic transitions and the adoption
of Western lifestyles [11].
Common obesity is caused by the interaction of multiple
genetic and environmental factors; with a heritability
ranging from 40 to 70% [12]. Genetic approaches have
improved our understanding of the biological bases
of obesity. To date, genome-wide association studies
(GWASs) have identified and confirmed 32 BMI loci
in European populations [13-19]. The replication oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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mandatory approach for characterizing gene-disease
relationships [20]. Because initial and replication studies
have been mainly reported in populations of European
descent, the challenge remains to extend the studies to
other populations [20]. Moreover, as each individual single
nucleotide polymorphism (SNP) exerts a moderate genetic
effect and thus explains a small proportion of the total
BMI variation, the analysis of the combined effect of sets
of variants (by calculating a genetic predisposition score
(GPS)) [21] appears necessary and also useful in moderate
sample size population samples which are underpowered
compared to GWASs.
In the present study, we assessed whether a GPS for
BMI developed from Europeans is a valid score in a North
African population. Although a few association studies
have been performed in this part of the world [22-26], no
one examined the combined set of established BMI loci.
Therefore, we tested whether the combination of variants
robustly associated with BMI in many European popula-
tions also influence anthropometric traits and obesity risk
in an Algerian population sample (provided by the ISOR
study).
Methods
The ISOR (InSulino-résistance à ORan) study
The cross-sectional population-based ISOR study was per-
formed from 2007 to 2009. The study’s objectives and
procedures were approved by the independent ethics
committee at the Algerian National Agency for the De-
velopment of Health Research (since renamed as the
Thematic Agency of Research in Health Sciences). The
ISOR study was a population-based, cross-sectional study
of a representative sample of 787 subjects (378 men and
409 women, aged between 30 and 64) recruited from
within the city of Oran (north-west of Algeria). Subjects
were selected at random from social security rolls. All sub-
jects consented freely to participation in the study. Details
of the studies have been described elsewhere [27].
A questionnaire on lifestyle (physical activity, tobacco use
and alcohol intake), personal and family medical histories,
current medication, socio-economic status and educational
level was completed during a face-to-face interview. The
ISOR questionnaire lifestyle was an adapted version of the
one used in the STEP study (investigation Stepwise led in
Algeria in 2003) which was validated by the WHO. The
level of physical activity was defined in quartiles as “none”,
“low”, “medium” and “high” after summing exercise scores
for sporting activities, walking, housework and physical
activity at work.
The anthropometric measurements included height,
body weight, waist and hip circumferences. Height and
weight were measured while the subject was barefoot
and lightly dressed. The BMI was calculated accordingto the Quetelet equation. Normal weight was consid-
ered for BMI < 25 kg/m2, overweight was considered
for 25 ≤ BMI < 30 kg/m2 and obesity was considered for
BMI ≥ 30 kg/m2.
Genomic DNA was extracted from white blood cells by
using the Stratagene® kit (Agilent Technologies, Les Ulis,
France), according to the manufacturer’s protocol.
SNP selection and genotyping
We selected 32 SNPs known to be associated with BMI
[19] within or near the following genes: FTO, MC4R,
TMEM18, GNPDA2, BDNF, NEGR1, SH2B1, ETV5,
MTCH2, KCTD15, TFAP2B, NRXN3, FAIM2, SEC16B,
RBJ-ADCY3-POMC, GPRC5B, MAP2K5-LBXCOR1, QPCTL-
GIPR, TNNI3K, SLC39A8, FLJ35779-HMGCR, LRRN6C,
TMEM160, FANCL, CADM2, PRKD1, LRP1B, PTBP2,
MTIF3-GTF3A, RPL27A-TUB, NUDT3-HMGA1 and
ZNF608.
Genotyping was performed using KASPar technology
(KBioscience, Hoddesdon, UK). The genotyping of the
ZNF608 rs4836133 SNP failed. The genotyping success
rates of the FANCL rs887912 and CADM2 rs13078807
SNPs were too low (75% and 76%, respectively) to be con-
sidered in the analyses. The genotyping success rate of the
29 other SNPs was at least 95%. So 29 SNPs were consid-
ered in the final analyses.
Statistical analysis
Statistical analyses were performed with SAS software
(version 9.1, SAS Institute Inc., Cary, NC, USA). Deviation
from the Hardy-Weinberg equilibrium was tested using a
χ2 test and the threshold for statistical significance was set
to p ≤ 0.0017 (with Bonferroni correction for 29 independ-
ent SNPs at α = 0.05).
The GPS was obtained as previously described [28].
Briefly, a weighting method was used to calculate the GPS
on the basis of 29 genotyped SNPs. The genotypes were
coded as 0, 1, or 2 according to the number of copies of
the effect allele. Each SNP was weighted according to its
relative effect size (i.e. the β coefficient); in order to meas-
ure the effect of each SNP on BMI with greater accuracy
and precision, β coefficients were derived from Speliotes
et al. [19]. The GPS was calculated by multiplying each
β-coefficient by the number of corresponding risk
alleles and then summing the products. Because this
produced a score out of 8.24 (twice the sum of the
reported β-coefficients), all values were divided by 8.24
and multiplied by 58 (number of alleles) to make the GPS
easier to interpret: each point of the GPS corresponds to
one risk allele. When calculating the GPS, missing geno-
type data were replaced with the average allele count for
the corresponding SNP. However, 47 individuals with
missing genotypes for more than 3 SNPs were excluded
from the GPS analyses.
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a general linear model using an additive genetic model. A
Pearson χ2 test was used to compare groups in terms of
genotype and allele distributions.
Odds ratios (ORs) were obtained by multivariate logistic
regression analyses with an additive genetic model.
For BMI and obesity risk, the covariables were age,
gender, smoking status and physical activity. For waist
circumference and hip circumference, the covariables were
age, gender, smoking status, physical activity and (in some
models) BMI.Table 1 Distributions of the 29 genotyped SNPs in the ISOR s
ISOR study
Nearby gene or locus SNP EA OA Genotype
0 1
FTO rs9939609 A T 278(0.37) 370
TMEM18 rs2867125 C T 21(0.03) 212
MC4R rs571312 A C 454(0.60) 267
GNPDA2 rs10938397 G A 256(0.35) 380
BDNF rs10767664 A T 31(0.04) 219
NEGR1 rs2815752 A G 69(0.09) 299
SH2B1 rs7359397 T C 547(0.73) 186
ETV5 rs9816226 T A 40(0.05) 252
MTCH2 rs3817334 T C 260(0.35) 335
KCTD15 rs29941 G A 59(0.08) 284
SEC16B rs543874 G A 522(0.69) 220
TFAP2B rs987237 G A 552(0.73) 176
FAIM2 rs7138803 A G 359(0.48) 319
NRXN3 rs10150332 C T 455(0.61) 256
RBJ rs713586 C T 203(0.27) 375
GPRC5B rs12444979 C T 8(0.01) 144
MAP2K5 rs2241423 G A 58(0.08) 274
QPCTL rs2287019 C T 34(0.05) 223
TNNI3K rs1514175 A G 229(0.30) 358
SLC39A8 rs13107325 T C 730(0.96) 33(0
FLJ35779 rs2112347 T G 78(0.11) 298
LRRN6C rs10968576 G A 590(0.78) 147
TMEM160 rs3810291 A G 209(0.28) 356
PRKD1 rs11847697 T C 569(0.76) 166
LRP1B rs2890652 C T 526(0.69) 212
PTBP2 rs1555543 C A 238(0.32) 378
MTIF3 rs4771122 G A 500(0.66) 225
RPL27A rs4929949 C T 277(0.37) 325
NUDT3 rs206936 G A 344(0.46) 323
EA: effect allele. OA: other allele. EAF: effect allele frequency. OAF: other allele freque
Genotypes were coded as 0/1/2, indicating the subject’s number of copies of the d
p HWE: p values for Hardy-Weinberg Equilibrium test.For individuals associations, after Bonferroni correc-
tion, only individuals associations with a p value below
0.0017 were considered to be statistically significant
(i.e. 0.05 divided by 29 polymorphisms).
For combined association (GPS analyses); statistical sig-
nificance was set to p ≤ 0.05. Power calculations for indi-
vidual SNP analyses were performed using Quanto v1.2.4
(http://biostats.usc.edu/Quanto.html) using a one-sided
p value at 0.05.
Concerning the GPS analysis, the statistical power of
detecting a significant association with BMI was 98%tudy
Speliotes et al. study
p HWE EAF/OAF EAF/OAF
2
(0.49) 106(0.14) 0.33 0.39/0.61 0.42/0.58
(0.28) 520(0.69) 0.96 0.83/0.17 0.83/0.17
(0.36) 31(0.04) 0.29 0.22/0.78 0.24/0.76
(0.51) 107(0.14) 0.08 0.40/0.60 0.43/0.57
(0.29) 496(0.67) 0.29 0.81/0.19 0.78/0.22
(0.41) 372(0.50) 0.43 0.70/0.30 0.61/0.39
(0.25) 17(0.02) 0.82 0.15/0.85 0.40/0.60
(0.34) 448(0.61) 0.59 0.78/0.22 0.82/0.18
(0.44) 160(0.21) 7.5×10−3 0.43/0.57 0.41/0.59
(0.37) 417(0.55) 0.25 0.74/0.26 0.67/0.33
(0.29) 18(0.02) 0.41 0.17/0.83 0.19/0.81
(0.23) 28(0.04) 4.0×10−3 0.15/0.85 0.18/0.82
(0.42) 73(0.10) 0.87 0.31/0.69 0.38/0.62
(0.34) 38(0.05) 0.76 0.22/0.78 0.21/0.79
(0.51) 163(0.22) 0.74 0.47/0.53 0.47/0.53
(0.19) 607(0.80) 0.89 0.89/0.11 0.87/0.13
(0.36) 419(0.56) 0.19 0.74/0.26 0.78/0.22
(0.30) 484(0.65) 0.19 0.80/0.20 0.80/0.20
(0.47) 170(0.23) 0.19 0.46/0.54 0.43/0.57
.04) - 0.54 0.02/0.98 0.07/0.93
(0.40) 364(0.49) 0.15 0.69/0.31 0.63/0.37
(0.19) 19(0.03) 7.3×10−3 0.12/0.88 0.31/0.69
(0.47) 190(0.25) 0.16 0.49/0.51 0.67/0.33
(0.22) 17(0.02) 0.21 0.13/0.87 0.04/0.96
(0.28) 19(0.03) 0.68 0.17/0.83 0.18/0.82
(0.51) 129(0.17) 0.32 0.43/0.57 0.59/0.41
(0.30) 27(0.04) 0.74 0.19/0.81 0.24/0.76
(0.44) 142(0.19) 8.4×10−3 0.41/0.59 0.52/0.48
(0.43) 79(0.11) 0.73 0.32/0.68 0.21/0.79
ncy.
esignated effect alleles.
Table 3 Effects of the genetic predisposition score and
covariables on BMI in the ISOR study (n = 740)
Models β SE LCL UCL p Explained variance (%)
Model 1 0.14 0.05 0.04 0.24 0.006 1.0
Model 2 0.15 0.05 0.06 0.24 0.001 14.1
The β coefficients represent the effect sizes.
SE: standard error; LCL: lower confidence limit; UCL: upper confidence limit.
Model 1: crude p value.
Model 2: p value adjusted for age, gender, physical activity and smoking status.
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Champely).
Results
Characteristics of the study subjects
The ISOR study includes 340 (43.2%) normal weight
subjects, 280 (35.6%) overweight subjects and 167 (21.2%)
obese subjects (Additional file 1).
Distributions and individual associations with
anthropometric traits
All 29 SNPs conformed to Hardy-Weinberg equilibrium
(Table 1). When we compared allelic frequencies of these
29 loci between the ISOR study and the study of Speliotes
et al., the allelic distributions differed for 5 SNPs (Table 1).
For example, for SH2B1 rs7359397, the T allele frequency
was 0.15 and 0.40 in the ISOR and Speliotes et al.’ studies,
respectively.
Power calculations indicated that, based on results from
Speliotes et al. [19], the statistical power of our study to
detect significant associations between individual SNPs
and BMI was below 44%. Nevertheless, the RBJ rs713586
and RPL27A rs4929949 SNPs were nominally associated
with BMI (β = 0.62 ± 0.25, p = 0.01, and β = 0.67 ± 0.24,
p = 0.006, respectively); and 23 of the 29 tested SNPs
were directionally consistent with the results reported
in the original GWAS on BMI (Additional file 2). This
result was greater than that expected by chance (Binomial
test, p = 0.0009).
Combined associations with anthropometric-related traits
and obesity risk
The 29 SNPs were used to calculate the GPS, which was
normally distributed (mean: 25.7 ± 3.7 alleles; range: 14.2
to 37.6 alleles). We observed significant associations be-
tween the GPS and BMI, waist circumference and hip
circumference (Table 2). The mean [95% CI] allele effect
of the GPS was +0.15 [0.06 - 0.24] kg/m2 (p = 0.001) for
BMI, +0.26 [0.03 - 0.49] cm (p = 0.02) for waist circum-
ference and +0.22 [0.04 - 0.40] cm (p = 0.02) for hip cir-
cumference. We did not detect a statistically significantTable 2 Effect of the genetic predisposition score on
anthropometric variables in the ISOR study (n = 740)
SE LCL UCL p p*
BMI (kg/m2) 0.15 0.05 0.06 0.24 0.001 -
Waist (cm) 0.26 0.12 0.03 0.49 0.02 0.23
Hip (cm) 0.22 0.09 0.04 0.40 0.02 0.60
Waist-to-hip ratio 0.001 0.001 −0.001 0.002 0.37 0.55
The β coefficients represent the effect sizes.
SE: standard error; LCL: lower confidence limit; UCL: upper confidence limit.
p values were adjusted for age, gender, physical activity and smoking status.
*p values were adjusted for age, gender, physical activity, smoking status and
BMI.association between the GPS and the waist-to-hip ratio
(p = 0.37). Associations with waist circumference and hip
circumference were no longer statistically significant after
further adjustment for BMI. Of note, when the analyses
did not take into account missing genotypes, similar
results were obtained for BMI, waist circumference, hip
circumference and the waist-to-hip ratio (data not shown).
To distinguish between the effects of the GPS and the
effects of the covariables classically associated with BMI
(age, gender, physical activity and smoking status), we
compared the crude and adjusted models (Table 3). The
GPS alone accounted for 1.0% of the BMI variance and
the covariables accounted for 13.1% of the variance. Over-
all, the GPS and covariables explained 14.1% of the BMI
variance.
Next, we investigated the association between the GPS
and the obesity risk. Because, overweight participants could
not be considered as obese or normal weight subjects,
we removed them for the analyses. We detected a sig-
nificant association between the GPS and the obesity
risk (OR [95%CI] = 1.11 [1.05 - 1.18], p = 0.0004). We also
examined the association between the obesity risk and the
GPS in quartiles (Table 4). Subjects in the highest GPS
quartile (i.e. > 28.3 alleles) had a higher obesity risk
than subjects in the lowest GPS quartile (i.e. < 23.2 alleles)
(OR = 2.53 [1.38 - 4.65], p = 0.003).
As the rs3817334, rs987237, rs10968576, rs4929949 SNPs
could be considered as outliners in terms of respect of the
Hardy-Weinberg equilibrium (4.0×10−3 ≤ p ≤ 8.4×10−3),
we performed all GPS analyses without these 4 SNPs and
similar results were obtained (data not shown).Table 4 The obesity risk per quartile of the genetic







p trend OR LCL UCL p
<23.2 91/33 0.0003 reference
[23.2 - 25.6] 87/33 0.88 0.46 1.67 0.69
[25.6 - 28.3] 71/36 1.62 0.82 3.13 0.16
>28.3 71/52 2.53 1.38 4.65 0.003
p values were adjusted for age, gender, physical activity and smoking status.
LCL: lower confidence limit; UCL: upper confidence limit.
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Meta-analyses of GWASs have identified 32 loci as being
unequivocally associated with BMI, individually or com-
bined in a genetic predisposition score in populations of
European descent [19]. In the present study, we have in-
vestigated the combined effects of 29 successfully geno-
typed, established BMI loci on anthropometric variables
and obesity risk in a sample of the general population
from north-west of Algeria (n = 740).
The prevalence of obesity in the ISOR study (21.2%) is
similar to that reported in Algeria (21.2%) in the Transi-
tion and Health Impact In North Africa (TAHINA) study
in 2010 [10]. The prevalence of obesity in Oran is higher
than in France (14.5%) [29], Spain (13.6%) [30] and Italy
(8.2%) [31], lower than in the USA (33.5%) [5], Canada
(23.1%) [6] and the UK (23.5%) [32], and similar to that in
Nigeria (21.2%) [33]. When compared with other urban
North African populations, the prevalence of obesity in
Oran is higher than in Morocco (14.9%) [8] and lower
than in Tunisia (29.6%) [9].
Although the ISOR study was not sufficiently powered
(<44%) to detect significant individual associations, most
of the tested SNPs presented effects with the expected
direction (23 of the 29 tested). We also observed that few
SNPs presented significant allele frequency differences be-
tween the ISOR and Speliotes et al. [19] studies. Differ-
ences in allele frequencies may contribute to differences in
disease prevalence between ethnic groups [34].
Although a few association studies on BMI or obesity
have been performed in North African samples [22-26],
no one examined the GWAS established BMI loci either
individually or combined. In the ISOR study, the GPS
(corresponding to the 29 established, BMI-associated SNPs’
cumulative contribution) for which we had 98% power in
the ISOR study, showed a significant, positive association
with BMI (p = 0.001). Each additional BMI-raising allele
was associated with a mean increment of 0.15 kg/m2
(which corresponds to a weight increment of 434 g for
a person measuring 1.70 m in height). Although the GPS
was also significantly associated with waist and hip
circumferences, these associations were mediated by BMI.
The overall known genetic susceptibility associated with
the GPS explained only 1.0% of the variance in BMI,
whereas the combined effect of genetic and known en-
vironmental factors accounted for 14.1%. Our results
are in agreement with previous reports [19,35]. More-
over, the GPS was associated with a 11% higher obesity
risk and subjects with more than 28.3 risk alleles had a
2.5-fold higher risk of obesity. Although (i) it has been
calculated that genetic factors account for between 40%
and 70% of the population variation in BMI and (ii) the
29 SNPs studied here have been robustly validated as
BMI-susceptible variants in GWA/replication studies, their
combined effect on BMI and obesity risk was quite small.However, our results are in agreement with previous
reports [16,19,35-39].
Conclusion
In conclusion, although larger samples will be needed to
firmly replicate our findings, our data showed that a GPS
comprising 29 BMI established loci in Europeans was as-
sociated with higher BMI and obesity risk in an Algerian
population. Our findings contribute to a better under-
standing of the genetic susceptibility to obesity in Algeria.
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